Immuno-Gene Therapy Committee

Aims & Scope

The Immuno-Gene Therapy Committee strives to:

  • Assist in the planning of the annual meeting scientific program and the review of submitted abstracts in the cell and gene therapy category.
  • Review the status of the immuno & gene therapy field and compile a list of major scientific issues that must be addressed to advance or enable cellular therapies utilizing immunotherapy and gene therapy.
  • Publish position papers and engage in scientific discourse as necessary to advance the field.

The Committee

Headshot of Michael Gustafson

Co-Chair

Michael Gustafson, PhD
May 2022 - Present

Mayo Clinic Arizona
Phoenix, USA

Headshot of Sandeep Soni

Co-Chair

Sandeep Soni, MD
May 2020 - Present

CRISPR Therapeutics
San Francisco, USA

Members

Alexey Bersenev, MD, PhD
Yale University
New Haven, United States

Jaap Jan Boelens, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, United States

Mitchell Cairo, MD
New York Medical College

New York, United States

Andrew Fesnak, MD
University of Pennsylvania

Philadelphia, United States

Patrick Hanley, PhD
Children's National Hospital

Washington, DC, United States

Yoon Seok Choi, MD, PhD
Ajou University School of Medicine

Suwon, Republic of Korea

Piriya Yoganathan, PhD, MBA
Ottawa Hospital Research Institute
Ottawa, Canada
ESP Leadership Development Program

Charlotte Hill Machado, PhD
IMPACT - Universidad de los Andes
Santiago, Chile
ESP Leadership Development Program

Dean Lee, MD, PhD
Nationwide Children's Hospital
Columbus, United States

Shari Pilon-Thomas, PhD
Moffitt Cancer Center
Tampa, United States

Paula Rio, PhD
CIEMAT

Madrid, Spain

Zulema Romero Garcia, PhD
University of California, Los Angeles

Los Angeles, United States

Branden Moriarity, PhD
University of Minnesota

Shoreview, United States

Nirali N. Shah, MD, MHSc
University of Minnesota

Shoreview, United States

David Steffin, MD
Texas Children’s Hospital

Houston, United States

Margaret Lamb, MD
Nationwide Children's Hospital

Columbus, United States

Applying to the Immuno-Gene Therapy Committee

The Committee evaluates membership needs during the first quarter of each year. If you are interested in contributing your expertise to the Committee, please submit your CV and a statement of interest to Andy Naqati (andy@isctglobal.org). Your statement of interest should be brief and describe your relevant expertise, your interest in joining the Committee, and how you envision yourself contributing to its activities.

Early-Stage Professionals (ESPs) should apply through the ESP Leadership Development Program.